Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

Click here to view
our current issue


Safety First

Preventing contamination with microorganisms is an essential requirement for pharma manufacturers. Thomas Hartung from the Johns Hopkins Bloomberg School of Public Health recommends using the monocyte activation test to reduce adverse drug reactions.

Thomas Hartung (September 2015)

Keywords: Non-endotoxin pyrogens, Adverse drug reaction, Human serum albumin, Gram-positive bacteria

    View full article    |    Back to Manufacturing section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |